Collaborative R34s for Pilot Studies of Innovative Treatments in Mental Disorders (Collaborative R34)

The summary for the Collaborative R34s for Pilot Studies of Innovative Treatments in Mental Disorders (Collaborative R34) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Collaborative R34s for Pilot Studies of Innovative Treatments in Mental Disorders (Collaborative R34): This Funding Opportunity Announcement (FOA), issued by the National Institute of Mental Health (NIMH), seeks to support collaborative preliminary intervention studies to evaluate the feasibility, tolerability, acceptability and safety of novel mechanism drug candidates, promising investigational new drugs (INDs), or novel psychosocial strategies for the treatment of mental disorders and for obtaining the preliminary data needed as a pre-requisite to larger-scale (efficacy or effectiveness) intervention or services studies. This FOA should be used when at least two but no more than three sites from different Institutions/Organizations are needed to complete the study. The collaborating studies should be organized in order to increase sample size, accelerate recruitment, and/or increase sample diversity and representation. For a linked set of collaborative R34s, each site shall have its own Program Director/Principal Investigator and provide for a mechanism for cross-site coordination, quality control, database management, statistical analysis, and reporting.
Federal Grant Title: Collaborative R34s for Pilot Studies of Innovative Treatments in Mental Disorders (Collaborative R34)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-12-071
Type of Funding: Grant
CFDA Numbers: 93.242
CFDA Descriptions: Mental Health Research Grants
Current Application Deadline: Jan 07, 2015
Original Application Deadline: Jan 07, 2015
Posted Date: January 4th, 2012
Creation Date: Jan 04, 2012
Archive Date: Feb 07, 2015
Total Program Funding:
Maximum Federal Grant Award: $225,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Targeted In Vivo Delivery of Gene Therapeutics for HIV Cure (R01 Clinical Trial Not Allowe...
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)
NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent...
Next-Generation Biologics for Sustained HIV Remission (R01 Clinical Trial Not Allowed)
Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P5...
Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...
Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...
Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
More Grants from the National Institutes of Health
NIH Directors Transformative Research Award (R01 - Clinical Trial Optional)
NIH Directors New Innovator Award Program (DP2 - Clinical Trial Optional)
Biomarkers Discovery In Parkinsonism (U01 Clinical Trial Optional)
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical...
Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R03 - Clinical T...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com